MaxCyte, Inc.
MXCT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $167,993 | $231,960 | $289,245 | $436,173 |
| - Cash | $12,973 | $15,225 | $23,385 | $27,884 |
| + Debt | $18,161 | $18,507 | $18,822 | $18,034 |
| Enterprise Value | $173,181 | $235,242 | $284,682 | $426,323 |
| Revenue | $6,829 | $8,507 | $10,390 | $8,693 |
| % Growth | -19.7% | -18.1% | 19.5% | – |
| Gross Profit | $6,313 | $6,988 | $8,893 | $6,412 |
| % Margin | 92.4% | 82.1% | 85.6% | 73.8% |
| EBITDA | -$11,568 | -$12,930 | -$11,018 | -$11,369 |
| % Margin | -169.4% | -152% | -106% | -130.8% |
| Net Income | -$12,416 | -$12,357 | -$10,261 | -$10,597 |
| % Margin | -181.8% | -145.3% | -98.8% | -121.9% |
| EPS Diluted | -0.12 | -0.12 | -0.1 | -0.1 |
| % Growth | 0% | -20% | 0% | – |
| Operating Cash Flow | -$7,458 | -$9,852 | -$14,411 | -$7,821 |
| Capital Expenditures | -$300 | -$584 | -$653 | -$147 |
| Free Cash Flow | -$7,758 | -$10,436 | -$15,064 | -$7,968 |